Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma

Published:2015-10-13 Issue:S1 Volume:38 Page:E1117-E1121
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Urban Damien¹,Corry June²³,Solomon Ben¹³,Lim Annette M.¹,Fua Tsien²,Coleman Andrew²,D'Costa Ieta²,Tiong Albert²,Liu Chen²,Peters Lester J.²³,Rischin Danny¹³

Affiliation:

1. Department of Medical Oncology; Peter MacCallum Cancer Centre; East Melbourne Victoria Australia

2. Department of Radiation Oncology; Peter MacCallum Cancer Centre; East Melbourne Victoria Australia

3. University of Melbourne; Parkville Australia

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.24169/fullpdf

Reference20 articles.

1. Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?;Quon;J Clin Oncol,2013

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

3. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis;O'Sullivan;J Clin Oncol,2013

4. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?;List;J Clin Oncol,2000

5. Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients;List;Head Neck,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study;International Journal of Radiation Oncology*Biology*Physics;2021-11

2. Human papillomavirus infection predicts better survival rate in patients with an oropharyngeal cancer;Archives of Medical Science;2021-08-26

3. Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution;Radiation Oncology;2020-11-10

4. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis;Oral Oncology;2018-11

5. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial;Oral Oncology;2017-06